Osaic Holdings’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.71M Buy
15,610
+1,433
+10% +$148K ﹤0.01% 2458
2026
Q1
$1.47M Sell
14,177
-1,846
-12% -$197K ﹤0.01% 2342
2025
Q4
$1.65M Sell
16,023
-6,522
-29% -$634K ﹤0.01% 2249
2025
Q3
$2.01M Buy
22,545
+420
+2% +$36.8K ﹤0.01% 2165
2025
Q2
$1.95M Buy
22,125
+9,992
+82% +$866K ﹤0.01% 1927
2025
Q1
$1.11M Sell
12,133
-42,770
-78% -$3.85M ﹤0.01% 2165
2024
Q4
$2.02M Buy
54,903
+32,164
+141% +$2.91M ﹤0.01% 1654
2024
Q3
$2.16M Sell
22,739
-1,979
-8% -$188K ﹤0.01% 1648
2024
Q2
$2.26M Sell
24,718
-8,530
-26% -$762K 0.01% 1525
2024
Q1
$3.02M Buy
33,248
+12,130
+57% +$1.06M 0.01% 1397
2023
Q4
$1.72M Buy
21,118
+7,559
+56% +$593K ﹤0.01% 1984
2023
Q3
$1.08M Buy
13,559
+3,470
+34% +$280K ﹤0.01% 2568
2023
Q2
$795K Buy
10,089
+3,690
+58% +$289K ﹤0.01% 2727
2023
Q1
$497K Sell
6,399
-1,731
-21% -$133K ﹤0.01% 3098
2022
Q4
$632K Sell
8,130
-21
-0.3% -$1.55K ﹤0.01% 2813
2022
Q3
$548K Buy
8,151
+5,341
+190% +$393K ﹤0.01% 2806
2022
Q2
$216K Buy
2,810
+440
+19% +$34.4K ﹤0.01% 3718
2022
Q1
$188K Sell
2,370
-18,976
-89% -$1.45M ﹤0.01% 4081
2021
Q4
$1.64M Buy
21,346
+12,578
+143% +$935K ﹤0.01% 1947
2021
Q3
$638K Sell
8,768
-25,309
-74% -$1.89M ﹤0.01% 2780
2021
Q2
$2.49M Buy
34,077
+31,879
+1,450% +$2.27M 0.01% 1531
2021
Q1
$151K Buy
2,198
+7
+0.3% +$482 ﹤0.01% 4002
2020
Q4
$146K Sell
2,191
-100
-4% -$6.41K ﹤0.01% 3754
2020
Q3
$142K Buy
2,291
+665
+41% +$42.1K ﹤0.01% 3540
2020
Q2
$101K Sell
1,626
-208
-11% -$12.6K ﹤0.01% 3681
2020
Q1
$100K Buy
+1,834
New +$113K ﹤0.01% 3478

Other funds holding PPH

Osaic Holdings's PPH Position: Q2 2026 in Review

Osaic Holdings increased its VanEck Pharmaceutical ETF (PPH) stake by 10% in Q2 2026, buying an estimated $148K and bringing the position to 15,610 shares worth $1.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2458.

Osaic Holdings first reported a position in PPH in Q1 2020 and has held it in 26 quarters since. The position peaked at $3.02M in Q1 2024. 148 funds tracked by Wall St. Rank hold PPH as of Q2 2026.

  • Osaic Holdings held 15,610 shares of VanEck Pharmaceutical ETF worth $1.71M as of Q2 2026.
  • Osaic Holdings bought 1,433 VanEck Pharmaceutical ETF shares in Q2 2026, an estimated $148K.
  • VanEck Pharmaceutical ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #2458 holding.
  • Osaic Holdings first reported a position in VanEck Pharmaceutical ETF in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's VanEck Pharmaceutical ETF position peaked at $3.02M in Q1 2024.
  • 148 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.